Tips About the Cordis INCRAFT Endograft

Area of Science:

• Vascular Surgery
• Endovascular Aortic Repair (EVAR)
• Aortic Aneurysm Treatment

Background:

• Introduction of the ultra low-profile Cordis INCRAFT AAA Stent-Graft System for endovascular aortic repair (EVAR) of infrarenal abdominal aortic aneurysms (iAAAs).
• The device has been in clinical use since November 2014, prompting an evaluation of initial experiences and technical aspects.

Purpose of the Study:

• To report the initial clinical experience with the Cordis INCRAFT AAA Stent-Graft System.
• To evaluate the safety, efficacy, and technical considerations of this novel endograft in treating iAAAs.

Main Methods:

• Retrospective collection of data from patients undergoing elective EVAR with the Cordis INCRAFT system from November 2014 to the present.
• Analysis of follow-up data to assess primary success, survival rates, complications, and device-related events.
• Statistical analysis using JMP software, with continuous variables reported as mean ± standard deviation and categorical variables as n (%).

Main Results:

• Ten patients (7 male, mean age 76.3 years) with iAAAs and challenging iliac anatomy underwent elective exclusion using the Cordis INCRAFT endoprosthesis.
• Primary success was achieved in 90% of cases; one patient required intervention for a type Ia endoleak, and another experienced intraoperative leg ischemia.
• Three patients (30%) experienced postimplantation syndrome; no other complications were noted during hospitalization or follow-up.

Conclusions:

• The Cordis INCRAFT AAA System proved to be a safe and effective device in this initial patient cohort.
• Further studies and shared experiences are anticipated to provide deeper insights into the technical aspects and long-term outcomes of this endograft.